THRIVITE 19- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium tablet, coated 
Method Pharmaceuticals, LLC

----------

Thrivite 19 Tablets

STATEMENT OF IDENTITY:

Thrivite 19 is an orally administered prescription dietary supplement and should be administered under the supervision of a licensed medical practitioner.

WARNING:

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

DOSAGE AND ADMINISTRATION:

One or two tablets daily, in divided doses, or as directed by a physician.

Each tablet contains:

Vitamin A (as beta carotene) ................................................. 1000 IU

Vitamin C (ascorbic acid) ........................................................ 100 mg

Vitamin D (as cholecalciferol) .................................................. 400 IU

Vitamin E (as dl-alpha tocopheryl acetate) ................................. 30 IU

Thiamine (Vitamin B1) ............................................................... 3 mg

Riboflavin (Vitamin B2) ............................................................... 3 mg

Niacin (as niacinamide) ........................................................... 15 mg

Vitamin B6 (as pyridoxine HCI) ................................................ 20 mg

Folate (folic acid) ...................................................................... 1 mg

Vitamin B12 (as cyanocobalamin) ............................................ 12 mcg

Pantothenic Acid (as calcium pantothenate) ................................ 7 mg

Calcium (as calcium carbonate) .............................................. 200 mg

Iron (as ferrous fumarate) ....................................................... 29 mg

Zinc (as zinc oxide) .................................................................. 20 mg

Docusate Sodium ..................................................................... 25 mg 

ALSO CONTAINS: Microcrystalline Cellulose, Pregelatinized Starch, Coating (Hypromellose, Titanium Dioxide, Polyvinyl Alcohol, Polyethylene Glycol, Talc), Croscarmellose Sodium, Magnesium Stearate, Stearic Acid, Fumed Silica.

HOW SUPPLIED:

Thrivite 19 tablets for oral administration are supplied as white, coated, oblong tablets debossed "M136", packaged in bottles of 100 tablets.

PRECAUTIONS/WARNING: 

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

STORAGE: Store at 20°-25° C (68°-77° F). Excursions permitted to 15°-30° C (59°-86° F). [See USP Controlled

Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container.

HEALTH CLAIMS:

Prescription Vitamin B9 Containing Dietary Supplement

PRINCIPAL DISPLAY PANEL

NDC 58657-136-01
Thrivite 19
Tablets

Rx

100 Tablets

PRINCIPAL DISPLAY PANEL
NDC 58657-136-01
Thrivite 19
Tablets
Rx
100 Tablets

THRIVITE 19 
.beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium tablet, coated
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:58657-136
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
.BETA.-CAROTENE (UNII: 01YAE03M7J) (.BETA.-CAROTENE - UNII:01YAE03M7J) .BETA.-CAROTENE1000 [iU]
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID100 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-30 [iU]
THIAMINE (UNII: X66NSO3N35) (Thiamine ION - UNII:4ABT0J945J) THIAMINE3 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN3 mg
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE15 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE20 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN12 ug
CALCIUM PANTOTHENATE (UNII: 568ET80C3D) (PANTOTHENIC ACID - UNII:19F5HK2737) PANTOTHENIC ACID7 mg
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CATION200 mg
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION29 mg
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION20 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM25 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
POLYVINYL ALCOHOL (UNII: 532B59J990)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
TALC (UNII: 7SEV7J4R1U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
ACACIA (UNII: 5C5403N26O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:58657-136-01100 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
DIETARY SUPPLEMENT06/15/2015
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
imprint
scoring1
shape
size (solid drugs)19 mm
Labeler - Method Pharmaceuticals, LLC (060216698)

Revised: 8/2015
Document Id: bf506fae-b05d-4403-8101-9fb5db17d7af
Set id: 48369e49-14c5-439d-a290-4686cdce2d31
Version: 3
Effective Time: 20150801
 
Method Pharmaceuticals, LLC